502 related articles for article (PubMed ID: 32919875)
1. Urinary biomarkers in bladder cancer: A review of the current landscape and future directions.
Ng K; Stenzl A; Sharma A; Vasdev N
Urol Oncol; 2021 Jan; 39(1):41-51. PubMed ID: 32919875
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers in Bladder Cancer Surveillance.
Sugeeta SS; Sharma A; Ng K; Nayak A; Vasdev N
Front Surg; 2021; 8():735868. PubMed ID: 34651010
[No Abstract] [Full Text] [Related]
3. Follow-up in non-muscle-invasive bladder cancer-International Bladder Cancer Network recommendations.
Kassouf W; Traboulsi SL; Schmitz-Dräger B; Palou J; Witjes JA; van Rhijn BW; Grossman HB; Kiemeney LA; Goebell PJ; Kamat AM
Urol Oncol; 2016 Oct; 34(10):460-8. PubMed ID: 27368880
[TBL] [Abstract][Full Text] [Related]
4. Can urinary biomarkers replace cystoscopy?
Maas M; Bedke J; Stenzl A; Todenhöfer T
World J Urol; 2019 Sep; 37(9):1741-1749. PubMed ID: 30283995
[TBL] [Abstract][Full Text] [Related]
5. Urinary biomarkers in bladder cancer: where do we stand?
Bhat A; Ritch CR
Curr Opin Urol; 2019 May; 29(3):203-209. PubMed ID: 30855372
[TBL] [Abstract][Full Text] [Related]
6. Urinary markers in the everyday diagnosis of bladder cancer.
Dal Moro F; Valotto C; Guttilla A; Zattoni F
Urologia; 2013; 80(4):265-75. PubMed ID: 24419920
[TBL] [Abstract][Full Text] [Related]
7. Bladder Cancer Diagnosis and Follow-Up: The Current Status and Possible Role of Extracellular Vesicles.
Oeyen E; Hoekx L; De Wachter S; Baldewijns M; Ameye F; Mertens I
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30769831
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic biomarkers in non-muscle invasive bladder cancer.
Faiena I; Rosser CJ; Chamie K; Furuya H
World J Urol; 2019 Oct; 37(10):2009-2016. PubMed ID: 30467596
[TBL] [Abstract][Full Text] [Related]
9. Novel urinary biomarkers for the detection of bladder cancer: A systematic review.
Tan WS; Tan WP; Tan MY; Khetrapal P; Dong L; deWinter P; Feber A; Kelly JD
Cancer Treat Rev; 2018 Sep; 69():39-52. PubMed ID: 29902678
[TBL] [Abstract][Full Text] [Related]
10. Clinical Decision Making in Surveillance of Non-Muscle-Invasive Bladder Cancer: The Evolving Roles of Urinary Cytology and Molecular Markers.
Zuiverloon TCM; de Jong FC; Theodorescu D
Oncology (Williston Park); 2017 Dec; 31(12):855-62. PubMed ID: 29297169
[TBL] [Abstract][Full Text] [Related]
11. Optimal Trial Design for Studying Urinary Markers in Bladder Cancer: A Collaborative Review.
Lotan Y; Black PC; Caba L; Chang SS; Cookson MS; Daneshmand S; Kamat AM; McKiernan JM; Pruthi RS; Ritch CR; Steinberg GD; Svatek RS; Zwarthoff EC
Eur Urol Oncol; 2018 Aug; 1(3):223-230. PubMed ID: 31102625
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic predictive value of Xpert Bladder Cancer Monitor in the follow-up of patients affected by non-muscle invasive bladder cancer.
D Elia C; Pycha A; Folchini DM; Mian C; Hanspeter E; Schwienbacher C; Vjaters E; Pycha A; Trenti E
J Clin Pathol; 2019 Feb; 72(2):140-144. PubMed ID: 30355587
[TBL] [Abstract][Full Text] [Related]
13. Urine markers for detection and surveillance of non-muscle-invasive bladder cancer.
Tilki D; Burger M; Dalbagni G; Grossman HB; Hakenberg OW; Palou J; Reich O; Rouprêt M; Shariat SF; Zlotta AR
Eur Urol; 2011 Sep; 60(3):484-92. PubMed ID: 21684071
[TBL] [Abstract][Full Text] [Related]
14. Urine-based biomarkers for the early detection and surveillance of non-muscle invasive bladder cancer.
Herman MP; Svatek RS; Lotan Y; Karakiewizc PI; Shariat SF
Minerva Urol Nefrol; 2008 Dec; 60(4):217-35. PubMed ID: 18923359
[TBL] [Abstract][Full Text] [Related]
15. Novel urinary biomarkers ADXBLADDER and bladder EpiCheck for diagnostics of bladder cancer: A review.
Wolfs JRE; Hermans TJN; Koldewijn EL; van de Kerkhof D
Urol Oncol; 2021 Mar; 39(3):161-170. PubMed ID: 33376063
[TBL] [Abstract][Full Text] [Related]
16. [Non-invasive urinary diagnosis of bladder cancer. What do we know?].
Kausch I; Böhle A
Urologe A; 2003 Jul; 42(7):912-21. PubMed ID: 12898034
[TBL] [Abstract][Full Text] [Related]
17. Current and emerging bladder cancer urinary biomarkers.
Parker J; Spiess PE
ScientificWorldJournal; 2011 May; 11():1103-12. PubMed ID: 21623456
[TBL] [Abstract][Full Text] [Related]
18. Measurements of complement factor H-related protein (BTA-TRAK assay) and nuclear matrix protein (NMP22 assay)--useful diagnostic tools in the diagnosis of urinary bladder cancer?
Mahnert B; Tauber S; Kriegmair M; Nagel D; Holdenrieder S; Hofmann K; Reiter W; Schmeller N; Stieber P
Clin Chem Lab Med; 2003 Jan; 41(1):104-10. PubMed ID: 12636058
[TBL] [Abstract][Full Text] [Related]
19. Bladder tumor markers: a review of the literature.
Volpe A; Racioppi M; D'Agostino D; Cappa E; Gardi M; Totaro A; Pinto F; Sacco E; Marangi F; Palermo G; Bassi PF
Int J Biol Markers; 2008; 23(4):249-61. PubMed ID: 19199274
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers of Bladder Cancer: Cell-Free DNA, Epigenetic Modifications and Non-Coding RNAs.
Harsanyi S; Novakova ZV; Bevizova K; Danisovic L; Ziaran S
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]